ATF-4 deficiency increases ER stress and induces osteoarthritis formation in mice

Peng-Yu Xie1, Shan-Shan Li1, Xu Liang1

  • 1Department of Rheumatology, First Affiliated Hospital of Zhengzhou University, No.1 Jianshe Dong Road, Zhengzhou, 450052, China.

Insights

Activating transcription factor 4 (ATF-4) is crucial for maintaining knee joint health. Its deficiency leads to osteoarthritis, but restoring ATF-4 can protect against joint damage.

Area of Science:

  • Skeletal Biology
  • Molecular Biology
  • Pathogenesis of Osteoarthritis

Background:

  • Osteoarthritis (OA) is a significant cause of morbidity with no current disease-modifying drugs.
  • Understanding OA pathogenesis is key to developing effective treatments.
  • Activating transcription factor 4 (ATF-4) is involved in cellular processes like ER stress and autophagy, crucial for skeletal health.

Purpose of the Study:

  • To investigate the role of Activating transcription factor 4 (ATF-4) in the pathogenesis of osteoarthritis.
  • To determine if ATF-4 deficiency exacerbates joint damage and OA development.
  • To explore the therapeutic potential of ATF-4 in osteoarthritis.

Main Methods:

  • Utilized Atf-4 deficient (Atf-4-/-) mice and wild-type (WT) littermates.
  • Induced meniscal injury in mice to study OA development.
  • Performed in vitro studies on articular chondrocytes from Atf-4-/- and WT mice.
  • Administered ATF-4 into the joint cavity of Atf-4-/- mice.

Main Results:

  • Meniscal injury in Atf-4-/- mice led to complete knee joint destruction and spontaneous OA-like lesions with aging.
  • Articular chondrocytes from Atf-4-/- mice showed increased ER stress, decreased proliferation, and enhanced apoptosis compared to WT.
  • Re-introduction of ATF-4 significantly reduced joint damage in Atf-4-/- mice.

Conclusions:

  • ATF-4 is essential for the normal function of articular chondrocytes and maintaining knee joint integrity.
  • ATF-4 deficiency accelerates OA pathogenesis.
  • Targeting ATF-4 presents a potential therapeutic strategy for osteoarthritis.